BioLife Solutions (BLFS) 10-Q 29 May 20 2020 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 26, 2020
Document Information [Line Items]
Entity Registrant Name	BIOLIFE SOLUTIONS INC
Entity Central Index Key	0000834365
Trading Symbol	blfs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		25,993,028
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false
Title of 12(b) Security	Common Shares, par value $0.01 per share

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 6,400,000	$ 6,448,000
Accounts receivable, trade, net	8,205,000	5,345,000
Inventories	10,829,000	10,972,000
Prepaid expenses and other current assets	1,016,000	1,348,000
Total current assets	26,450,000	24,113,000
Assets held for rent, net	4,875,000	3,922,000
Property and equipment, net	5,407,000	5,572,000
Operating lease right-of-use assets, net	892,000	1,040,000
Long-term deposits and other assets	36,000	50,000
Investments	2,500,000	2,500,000
Accrued interest receivable	27,000
Intangible assets, net	21,294,000	21,982,000
Goodwill	33,506,000	33,637,000
Total assets	94,987,000	92,816,000
Current liabilities
Accounts payable	3,522,000	3,119,000
Accrued expenses and other current liabilities	3,080,000	3,369,000
Lease liabilities, operating, current portion	826,000	804,000
Contingent consideration, current portion	365,000	377,000
Warrant liability	17,667,000
Total current liabilities	25,460,000	7,669,000
Warrant liability		39,602,000
Contingent consideration, long-term	1,486,000	1,537,000
Lease liabilities, operating, long-term	332,000	550,000
Other long-term liabilities		4,000
Total liabilities	27,278,000	49,362,000
Commitments and Contingencies (Note 11)
Shareholders’ equity
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
Common stock, $0.001 par value; 150,000,000 shares authorized, 21,148,771 and 20,825,452 shares issued and outstanding at March 31, 2020 and December 31 2019, respectively	21,000	21,000
Additional paid-in capital	145,432,000	143,485,000
Accumulated deficit	(77,744,000)	(100,052,000)
Total shareholders’ equity	67,709,000	43,454,000
Total liabilities and shareholders’ equity	$ 94,987,000	$ 92,816,000

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	150,000,000	150,000,000
Common stock, issued (in shares)	21,148,771	20,825,452
Common stock, outstanding (in shares)	21,148,771	20,825,452
Series A Preferred Stock [Member]
Preferred stock, shares designated (in shares)	4,250	4,250
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0

Statements of Operations (Unaud

Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue	$ 12,162,000	$ 5,770,000
Operating expenses
Cost of product and rental revenue (exclusive of intangible assets amortization)	4,568,000	1,647,000
Research and development	1,663,000	359,000
Sales and marketing	1,576,000	837,000
General and administrative	3,135,000	2,153,000
Amortization of intangible assets	688,000	0
Acquisition costs	225,000	208,000
Change in fair value of contingent consideration	(63,000)
Total operating expenses	11,792,000	5,204,000
Operating income (loss)	370,000	566,000
Other income (expense)
Change in fair value of warrant liability	21,914,000	(19,663,000)
Interest income	29,000	171,000
Interest expense	(1,000)	(3,000)
Other expense	(4,000)
Loss from equity method investment in SAVSU		(232,000)
Total other income (expenses)	21,938,000	(19,727,000)
Net income (loss) before provision for income taxes	22,308,000	(19,161,000)
Income tax (benefit)
Net income (loss)	22,308,000	(19,161,000)
Net income attributable to common stockholders:
Basic	18,364,000	(19,161,000)
Diluted	$ (174,000)	$ (19,161,000)
Earnings per share attributable to common stockholders
Basic (in dollars per share)	$ 0.87	$ (1.03)
Diluted (in dollars per share)	$ (0.01)	$ (1.03)
Weighted average shares used to compute earnings per share attributable to common stockholders:
Basic (in shares)	21,010,817	18,648,397
Diluted (in shares)	21,010,817	18,648,397
Product [Member]
Revenue	$ 11,727,000	$ 5,770,000
Rental Revenue [Member]
Revenue	$ 435,000

Statements of Shareholders' Equ

Statements of Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member]Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2018		18,547,406
Balance at Dec. 31, 2018		$ 19	$ 113,008	$ (98,395)	$ 14,632
Stock-based compensation			531		531
Stock option exercises (in shares)		99,697
Stock option exercises			161		161
Warrant exercises (in shares)		5,000
Warrant exercises			97		97
Stock issued – on vested RSUs (in shares)		64,992
Stock issued – on vested RSUs
Net loss				(19,161)	(19,161)
Net income				(19,161)	(19,161)
Balance (in shares) at Mar. 31, 2019		18,717,095
Balance at Mar. 31, 2019		$ 19	113,797	(117,556)	(3,740)
Balance (in shares) at Dec. 31, 2019		20,825,452
Balance at Dec. 31, 2019		$ 21	143,485	(100,052)	43,454
Stock-based compensation			1,113		1,113
Stock option exercises (in shares)		268,293
Stock option exercises			490		490
Warrant exercises (in shares)		2,000
Warrant exercises			30		30
Stock issued – on vested RSUs (in shares)		53,026
Stock issued – on vested RSUs
Net loss				22,308	22,308
Stock issued as 2019 bonus payout			314		314
Net income				22,308	22,308
Balance (in shares) at Mar. 31, 2020		21,148,771
Balance at Mar. 31, 2020		$ 21	$ 145,432	$ (77,744)	$ 67,709

Statements of Cash Flows (Unaud

Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities
Net loss		$ 22,308,000	$ (19,161,000)
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation		413,000	98,000
Amortization of intangible assets		688,000	0
Stock-based compensation		1,113,000	531,000
Non cash lease expense	[1]	148,000	124,000
Gain from equity method investment in SAVSU			232,000
Change in fair value of contingent consideration		(63,000)
Change in fair value of warrant liability		(21,914,000)	19,663,000
Change in operating assets and liabilities
Accounts receivable, trade		(2,929,000)	118,000
Inventories		143,000	(551,000)
Prepaid expenses and other current assets		317,000	6,000
Increase (Decrease) in Accounts Payable, Total		561,000
Accrued expenses and other current liabilities	[1]	304,000	(469,000)
Other		(402,000)	555,000
Net cash provided by operating activities		687,000	1,146,000
Cash flows from investing activities
Purchase of property and equipment		(146,000)
Purchase of assets held for rent, net		(1,081,000)	(156,000)
Net cash used in investing activities		(1,227,000)	(156,000)
Cash flows from financing activities
Proceeds from exercise of common stock options		490,000	161,000
Proceeds from exercise of warrants		9,000	23,000
Other		(7,000)	(7,000)
Net cash provided by financing activities		492,000	177,000
Net increase (decrease) in cash and cash equivalents		(48,000)	1,167,000
Cash and cash equivalents - beginning of period		6,448,000	30,657,000
Cash and cash equivalents - end of period		6,400,000	31,824,000
Non-cash investing and financing activities
Reclassification of warrant liability to equity upon exercise		21,000	73,000
Purchase of property & equipment not yet paid		6,000	46,000
Stock issued as 2019 bonus payout		$ 314,000
[1]	Reclass of operating lease liabilities related to updated treatment of leases under ASC 842

Note 1 - Organization and Signi

Note 1 - Organization and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	1. Business BioLife Solutions, Inc. (“BioLife,” “us,” “we,” “our,” or the “Company”) is a leading developer, manufacturer and supplier of a portfolio of bioproduction tools including; proprietary biopreservation media, automated thawing devices, cloud-connected shipping containers, and freezer technology for cell and gene therapies. Our CryoStor® freeze media and HypoThermosol® hypothermic storage are optimized to preserve cells in the regenerative medicine market. These novel biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function. Our ThawSTAR® product line is comprised of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. These products improve the quality of administration of high-value, temperature-sensitive biologic therapies to patients by standardizing the thawing process and reducing the risks of contamination and overheating, which are inherent with the use of traditional water baths. Our evo shipping containers are innovative high-performance cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. Basis of Presentation The condensed consolidated financial statements included herein have been prepared by BioLife Solutions, Inc. in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for Quarterly Reports on Form 10 10 X not 10 December 31, 2019. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Astero Bio Corporation (“Astero,” and the Astero product line, “ThawStar” acquired on April 1, 2019), August 8, 2019), November 12, 2019). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows. The results of operations for the interim periods presented are not Financial Statement Reclassification Certain classifications on the Condensed Consolidated Statements of Cash Flows related to Non cash lease expense and Accrued expenses and other current liabilities for the three March 31, 2019 no Significant Accounting P olicies There have been no three March 31, 2020, 10 Liquidity and Capital Resources On March 31, 2020 December 31, 2019, $6.4 April 1, 2019 $12.5 $8.5 not $484,000 2019 second 2020. August 8, 2019, 1,100,000 November 12, 2019, $11.0 $4.0 $15.0 not On May 22, 2020, $20 12 not 19 not may may 19 may not Risks and Uncertainties On March 10, 2020, 19 one 19 six nine no We have already experienced certain disruptions to our business such as temporary closure of our offices and similar disruptions may may 19 19 may may 19 19 19 There are many uncertainties regarding the current pandemic of the novel coronavirus (“COVID- 19” 19 19 not first March 31, 2020, 19 may $1.5 $2.0 may 19 Concentrations of credit risk and business risk In the three March 31, 2020, 25% two three March 31, 2019, 34% two No 10% three March 31, 2020 2019. three March 31, 2020 2019, 66% 90%, 2019, December 31, 2020. March 31, 2020, two 33% December 31, 2019, two 25% The following table represents the Company’s total revenue by geographic area (based on the location of the customer): Three Months Ended March 31, Revenue by customers’ geographic locations 2020 2019 United States 74 % 60 % Canada 11 % 23 % Europe, Middle East, Africa (EMEA) 12 % 13 % Other 3 % 4 % Total revenue 100 % 100 % Recent accounting pronouncements In August 2018, 2018 13, 820 2018 13 8: December 31, 2020 January 1, 2020 no In December 2019, 2019 12, 740 2019 12 740, not 2019 12 December 31, 2021, 2020. no 2019 12 In June 2016, No. 2016 13, 326 2016 13 2016 13 December 15, 2022, In August 2018, No. 2018 15, 350 40 2018 15 December 15, 2019, January 1, 2020. January 1, 2020 no

Note 2 - Fair Value Measurement

Note 2 - Fair Value Measurement	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Fair Value Disclosures [Text Block]	2. Fair Value Measurement In accordance with FASB ASC Topic 820, 820” 820 820 three Level 1 Level 2 1 not Level 3 As of March 31, 2020 December 31, 2019, There were no three March 31, 2020 not The following tables set forth the Company’s financial assets measured at fair value on a recurring basis as of March 31, 2020 December 31, 2019, three (In thousands) As of March 31, 20 20 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 6,400 $ — $ — $ 6,400 Convertible debt held at fair value — — 1,000 1,000 Total 6,400 — 1,000 7,400 Liabilities: Contingent consideration - business combinations — — 1,851 1,851 Warrant liability — — 17,667 17,667 Total $ — $ — $ 19,518 $ 19,518 As of December 31, 2019 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 6,448 $ — $ — $ 6,448 Convertible debt held at fair value — — 1,000 1,000 Total 6,448 — 1,000 7,448 Liabilities: Contingent consideration - business combinations — — 1,914 1,914 Warrant liability — — 39,602 39,602 Total $ — $ — $ 41,516 $ 41,516 The fair values of money market funds classified as Level 1 3 no 3 March 31, December 31, (In thousands) 2020 2019 Beginning balance $ 1,000 $ 1,000 Purchases — — Change in fair value recognized in net income — — Total $ 1,000 $ 1,000 The following table presents the changes in fair value of contingent consideration liabilities which are measured using Level 3 March 31, December 31, (In thousands) 2020 2019 Beginning balance $ 1,914 $ — Additions — 2,347 Change in fair value recognized in net income (63 ) 50 Payments earned, reclassified to accrued liabilities — (483 ) Total $ 1,851 $ 1,914 The following table presents the changes in fair value of warrant liabilities which are measured using Level 3 March 31, December 31, (In thousands) 2020 2019 Beginning balance $ 39,602 $ 28,516 Exercised warrants (21 ) (1,749 ) Change in fair value recognized in net income (21,914 ) 12,835 Ending balance $ 17,667 $ 39,602

Note 3 - Acquisitions

Note 3 - Acquisitions	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Business Combination Disclosure [Text Block]	3. Astero Acquisition On April 1, 2019, In connection with the acquisition, the Company paid (i) a base payment in the amount of $12.5 x $8.0 $4.5 one 2019, 2020 2021 $3.5 $5.0 2021, three 2019 2021. Consideration transferred The Astero acquisition was accounted for as a purchase of a business under FASB ASC Topic 805, $12.5 $8.5 three $1.5 $324,000, $4.1 $9.5 not may Total consideration recorded for the acquisition of Astero is as follows (amounts in thousands): Cash consideration $ 12,521 Contingent consideration 1,491 Working capital adjustment (71 ) Total consideration transferred $ 13,941 Fair Value of Net Assets Acquired The table below represents the purchase price allocation to the net assets acquired based on their estimated fair values (amounts in thousands). Such amounts were estimated using the most recent financial statements from Astero as of March 31, 2019. Cash and cash equivalents $ 11 Accounts receivable, net 154 Inventory 456 Customer relationships 160 Tradenames 470 Developed technology 2,840 In-process research and development 650 Goodwill 9,515 Other assets 99 Accounts payable (250 ) Other liabilities (164 ) Fair value of net assets acquired $ 13,941 The fair value of Astero’s identifiable intangible assets and estimated useful lives have been estimated as follows (amounts in thousands except years): Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 160 4 Tradenames 470 9 Developed technology 2,840 5 – 9 In-process research and development 650 9 Total identifiable intangible assets $ 4,120 Fair value measurement methodologies used to calculate the value of any asset can be broadly classified into one three three third Some of the more significant assumptions inherent in the development of intangible asset fair values, from the perspective of a market participant, include, but are not not Acquired Goodwill The goodwill of $9.5 $1.1 not SAVSU Acquisition On August 8, 2019, 8,616 56% not 1,100,000 August 8, 2019, Consideration transferred The SAVSU acquisition was accounted for as a purchase of a business under FASB ASC Topic 805, 56% 1,100,000 $18.12 $19.9 100% $35.8 $5.8 $15.9 44% 56% not $10.1 Under the acquisition method of accounting, the assets acquired and liabilities assumed from SAVSU were recorded as of the acquisition date, at their respective fair values, and consolidated with those of BioLife. The fair value of the net tangible assets acquired is estimated to be approximately $4.2 $12.2 $19.5 not may Total consideration paid for the acquisition of SAVSU is as follows (amounts in thousands): Stock consideration for 55.6% equity interest purchased $ 19,932 This stock consideration plus the fair value of our existing equity investment in SAVSU of $15.9 $35.8 Fair Value of Net Assets Acquired The table below represents the purchase price allocation to the net assets acquired based on their estimated fair values (amounts in thousands). Such amounts were estimated using the most recent financial statements from SAVSU as of August 7, 2019. Cash and cash equivalents $ 1,251 Accounts receivable, net 753 Prepaid expenses and other current assets 19 Property, plant and equipment, net 546 Operating right-of-use asset 233 Assets held for rent, net 2,441 Customer relationships 80 Tradenames 1,320 Developed technology 10,750 Goodwill 21,037 Accounts payable and accrued expenses (807 ) Deferred tax liabilities (1,541 ) Other liabilities (232 ) Fair value of net assets acquired $ 35,850 The fair value of SAVSU’s identifiable intangible assets and estimated useful lives have been estimated as follows (amounts in thousands except years): Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 80 6 Tradenames 1,320 9 Developed technology 10,750 7 – 8 Total identifiable intangible assets $ 12,150 Fair value measurement methodologies used to calculate the value of any asset can be broadly classified into one three three Some of the more significant assumptions inherent in the development of intangible asset fair values, from the perspective of a market participant, include, but are not not Acquired Goodwill The goodwill of $21.0 None Custom Biogenic Systems Acquisition On November 10, 2019, November 12, 2019. In connection with the CBS Acquisition, we paid to CBS Seller (i) a base payment in the amount of $15.0 $11.0 $550,000 $4.0 $3.0 March 13, 2019, 2020, 2021, 2022, 2023 2024 not $15.0 The CBS acquisition was accounted for as a purchase of a business under FASB ASC Topic 805, $6.0 $6.8 $3.1 not may Total consideration transferred (in thousands): Cash consideration $ 11,000 Stock consideration 4,000 Contingent consideration 856 Total consideration transferred $ 15,856 Fair Value of Net Assets Acquired The table below represents the purchase price allocation to the net assets acquired based on their fair values (amounts in thousands). Such amounts were estimated using the most recent financial statements from CBS as of November 11, 2019. Accounts receivable, net $ 1,044 Inventory 3,232 Prepaid expenses and other current assets 29 Property, plant and equipment, net 3,615 Customer relationships 560 Tradenames 800 Developed technology 5,430 Goodwill 2,954 Accounts payable (1,197 ) Other liabilities (611 ) Fair value of net assets acquired $ 15,856 The fair value of CBS’s identifiable intangible assets and weighted average useful lives have been estimated as follows (amounts in thousands except years): Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 560 6 Tradenames 800 6 Developed technology 5,430 9 Total identifiable intangible assets $ 6,790 Fair value measurement methodologies used to calculate the value of any asset can be broadly classified into one three three Some of the more significant assumptions inherent in the development of intangible asset fair values, from the perspective of a market participant, include, but are not not Acquired Goodwill The goodwill of $3.0

Note 4 - Inventory

Note 4 - Inventory	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Inventory Disclosure [Text Block]	4 . Inventory Inventory consists of the following at March 31, 2020 December 31, 2019: (In thousands) March 31, 20 20 December 31, 201 9 Raw materials $ 3,282 $ 2,979 Work in progress 1,658 1,896 Finished goods 5,889 6,097 Total $ 10,829 $ 10,972

Note 5 - Assets Held for Rent

Note 5 - Assets Held for Rent	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Assets Held For Rent [Text Block]	5. Assets held for rent Assets held for rent consist of the following at March 31, 2020 December 31, 2019: (In thousands) March 31, 2020 December 31, 2019 Shippers placed in service $ 3,748 $ 3,073 Accumulated deprecation (302 ) (174 ) Net 3,446 2,899 Shippers and related components in production 1,429 1,023 Total $ 4,875 $ 3,922 Shippers and related components in production include shippers complete and ready to be deployed and placed in service upon a customer order, shippers in the process of being assembled, and components available to build shippers. We recognized $128,000 three March 31, 2020. not three March 31, 2019

Note 6 - Goodwill and Intangibl

Note 6 - Goodwill and Intangible Assets	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	6. Goodwill Goodwill represents the difference between the purchase price and the estimated fair value of identifiable assets acquired and liabilities assumed. Goodwill acquired in a business combination and determined to have an indefinite useful life is not 350. three March 31, 2020: (In thousands) Balance as of December 31, 2019 $ 33,637 Correction of an error related to CBS goodwill (131 ) Balance as of March 31, 2020 $ 33,506 We adjusted goodwill from the CBS acquisition related to an immaterial error of $131,000 December 31, 2019. $131,000. Intangible Assets Intangible assets, net consisted of the following at March 31, 2020: (In thousands, except weighted average useful life) March 31, 2020 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (88 ) $ 712 5.0 Tradenames 2,590 (205 ) 2,385 7.4 Technology – acquired 19,020 (1,473 ) 17,547 7.8 In-process R&D (1) 650 — 650 9.0 Total intangible assets $ 23,060 $ (1,766 ) $ 21,294 7.7 ( 1 not second 2020. Intangible assets, net consisted of the following at December 31, 2019: (In thousands, except weighted average useful life) December 31, 2019 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (51 ) $ 749 5.6 Tradenames 2,590 (123 ) 2,467 8.1 Technology – acquired 19,020 (904 ) 18,116 8.4 In-process R&D (1) 650 — 650 9.0 Total intangible assets $ 23,060 $ (1,078 ) $ 21,982 8.3 ( 1 not second 2020. Amortization expense for finite-lived intangible assets was $688,000 three March 31, 2020. no three March 31, 2019. second 2020, 9 March 31, 2020, (In thousands) For the Years Ended December 31, Estimated Amortization Expense 2020 (9 months remaining) $ 2,100 2021 2,825 2022 2,825 2023 2,795 2024 2,770 Thereafter 7,979 Total $ 21,294

Note 7 - Share-based Compensati

Note 7 - Share-based Compensation	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Share-based Payment Arrangement [Text Block]	7 . Share-based Compensation Service Vesting-Based Stock Options The following is a summary of service vesting based stock option activity for the three March 31, 2020, March 31, 2020: Three Month s Ended March 31, 20 20 Options Weighted Avg. Exercise Price Outstanding at beginning of period 1,570,455 $ 1.96 Granted — $ — Exercised (251,180 ) $ 1.84 Forfeited — $ — Expired — $ — Outstanding at March 31, 2020 1,319,275 $ 1.98 Service vesting-based stock options exercisable at March 31, 2020 1,263,377 $ 1.96 We recognized stock compensation expense of $61,000 $144,000 three March 31, 2020 2019, March 31, 2020, $9.9 $9.5 March 31, 2020. March 31, 2020 2019 $3.0 $1.4 March 31, 2020 $86,000 1.2 Performance-based Stock Options The following is a summary of performance-based stock option activity under our stock option plans for the three March 31, 2020, March 31, 2020: Three Month s Ended March 31, 2020 Options Wtd. Avg. Exercise Price Outstanding at beginning of period 737,497 $ 1.64 Granted — $ — Exercised (17,113 ) $ 1.64 Outstanding performance-based at March 31, 2020 720,384 $ 1.64 Performance-based stock options exercisable at March 31, 2020 720,384 $ 1.64 As of March 31, 2020, $5.7 March 31, 2020. March 31, 2020, 1.7 March 31, 2020 There were no three March 31, 2020 2019. Restricted Stock Service vesting-based restricted stock The following is a summary of service vesting-based restricted stock activity for the three March 31, 2020, March 31, 2020: Thr ee Months Ended March 31, 20 20 Number of Grant-Date Unvested outstanding at beginning of period 429,399 $ 13.25 Granted 175,971 $ 9.43 Vested (53 026 ) $ 12.90 Forfeited (7,000 ) $ 15.92 Unvested outstanding at March 31, 2020 545,344 $ 12.01 The aggregate fair value of the service vesting-based awards granted during the three March 31, 2020 2019 $1.7 $2.6 $813,000 $853,000 three March 31, 2020 March 31, 2019, We recognized stock compensation expense of $394,000 $255,000 three March 31, 2020 March 31, 2019, March 31, 2020, $5.7 3.3 Performance-based restricted stock On March 25, 2020 82,805 2020 0% 125% $9.18 December 31, 2020. We recognized stock compensation expense of $189,000 three March 31, 2020 March 31, 2020, $571,000 0.8 Performance-based restricted stock in lieu of cash On March 25, 2020 34,154 $9.18 2019 September 25, 2020 December 31, 2019. Market-based restricted stock On February 25, 2019 94,247 April 1, 2019 29,604 0% 200% January 1, 2019 December 31, 2020 20 69%, 0% 2.5%. 2 0% 2 December 31, 2020. On March 25, 2020 109,140 0% 200% January 1, 2020 December 31, 2021 20 78%, 0% 0.3%. 2 0% 2 December 31, 2021. We recognized stock compensation expense of $469,000 $132,000 three March 31, 2020 2019, March 31, 2020, $2.6 1.2 We recorded total stock compensation expense for the three March 31, 2020 2019, Three Months Ended March 31, (In thousands) 20 20 201 9 Research and development costs $ 174 $ 67 Sales and marketing costs 229 154 General and administrative costs 577 278 Cost of product sales 133 32 Total $ 1,113 $ 531

Note 8 - Warrants

Note 8 - Warrants	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Warrants [Text Block]	8 . Warrants In March 2014, 6,910,283 $4.75 March 2021. In May 2016, 550,000 $1.75 May 2021. The following table summarizes warrant activity for the three March 31, 2020: Shares Wtd. Avg. Exercise Price Outstanding at December 31, 2019 3,959,005 $ 4.33 Exercised (2,000 ) 4.75 Outstanding at March 31, 2020 3,957,005 $ 4.33 On May 14, 2020, Taurus4757 2,747,970 3,871,405 85,600 $4.75.

Note 9 - Income Taxes

Note 9 - Income Taxes	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Income Tax Disclosure [Text Block]	9. The Company accounts for income taxes under ASC Topic 740 We have recorded a full valuation allowance against our deferred tax assets. As we continue to have multiple quarters of positive net income, we will assess our valuation allowance. Based on all available evidence, we determined that we have not March 31, 2020. may On March 27, 2020, no 2020

Note 10 - Net Income (Loss) Per

Note 10 - Net Income (Loss) Per Common Share	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Earnings Per Share [Text Block]	10 . Net Income (Loss) per Common Share The Company considers its unexercised warrants and unvested restricted shares, which contain non-forfeitable rights to dividends, participating securities, and includes such participating securities in its computation of earnings per share pursuant to the two two two In periods when we have a net loss, common stock equivalents are excluded from our calculation of earnings per share as their inclusion would have an antidilutive effect. For the three March 31, 2020, 1.9 2.7 three March 31, 2019, 2.7 3.0 The following table presents computations of basic and diluted earnings per share under the two Three Month s Ended March 31, (In thousands, except per share and share data) 2 020 201 9 Numerator: Net income (loss) attributable to common stockholders: Basic $ 18,364 $ (19,161 ) Diluted $ (174 ) $ (19,161 ) Denominator: Basic and diluted weighted average shares outstanding 21,010,817 18,648,397 Basic earnings per share $ 0.87 $ (1.03 ) Diluted earnings per share $ (0.01 ) $ (1.03 )

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	1 1 . Commitments and Contingencies Employment agreements We have employment agreements with our Chief Executive Officer, Chief Financial and Operating Officer, Chief Science Officer, Chief Quality Officer, Chief Marketing Officer, Chief Revenue Officer, Vice President, Freezer Technologies, and Vice President, Cold Chain Technologies Sales. None may Litigation From time to time, the Company is subject to various legal proceedings that arise in the ordinary course of business, none may not Indemnification As permitted under Delaware law and in accordance with the Company’s bylaws, the Company is required to indemnify its officers and directors for certain errors and occurrences while the officer or director is or was serving in such capacity. The Company is also party to indemnification agreements with its directors. The Company believes the fair value of the indemnification rights and agreements is minimal. Accordingly, the Company has not March 31, 2020.

Note 12 - Revenue

Note 12 - Revenue	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	1 2 . Revenue We currently operate as one We generate revenue from the sale of bioproduction products, equipment devices, and related consumables used with these equipment devices to customers in the life science and biopharmaceutical industries. Under ASC 606, The Company also generates revenue from the leasing of our evo cold chain systems, which are typically cloud-connected shippers with enabling cold chain cloud applications, to customers pursuant to rental arrangements entered into with the customer. Revenue from the rental of cold chain systems is not 606 842, The following table represents revenues by product line: Three Months Ended March 31, (In thousands, except percentages) 2020 2019 Biopreservation media $ 8,672 $ 5,770 Automated thawing 394 –– evo shippers 438 –– Freezers and accessories 2,658 –– Total revenue $ 12,162 $ 5,770

Note 13 - Leases

Note 13 - Leases	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Lessee, Leases [Text Block]	1 3 . Leases We lease approximately 32,106 July 31, 2021 two five first August 1, 2021, second first $63,000 March 31, 2020, August October We lease approximately 1,250 July 1, 2020. $5,000 March 31, 2020. We lease approximately 9,932 December 31, 2021 two three first December 1, 2021, second December 1, 2024. $9,000 March 31, 2020, We lease approximately 106,998 November 30, 2020 one sixty November 12, 2020. not 842, not 12 two not $15,000 March 31, 2020, Operating leases recorded on our condensed consolidated balance sheet are primarily related to our Bothell, Washington headquarters space lease and our Albuquerque, New Mexico, SAVSU, space lease. We have not not not one Our financing lease is related to research equipment. We used a weighted average discount rate of 6.5%, 8.1%, 1.5 0.9 $1.3 $1.8 $233,000 $232,000 three March 31, 2020 $229,000, $170,000 $59,000 not three March 31, 2020 $217,000. three March 31, 2019, 840 $142,000. Maturities of our operating lease liabilities as of March 31, 2020 (In thousands) Operating Leases Financing Leases 2020 $ 656 $ 11 2021 559 3 Total lease payments 1,215 14 Less: interest (57 ) (1 ) Total present value of lease liabilities $ 1,158 $ 13

Note 14 - Consolidated Balance

Note 14 - Consolidated Balance Sheet Detail	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Supplemental Balance Sheet Disclosures [Text Block]	14. C ondensed Consolidated Balance Sheet Detail Property and Equipment (In thousands) March 31, 2020 December 31, 2019 Property and equipment Leasehold improvements $ 2,137 $ 2,112 Furniture and computer equipment 810 794 Manufacturing and other equipment 5,261 5,187 Subtotal 8,208 8,093 Less: Accumulated depreciation (2,801 ) (2,521 ) Net property and equipment $ 5,407 $ 5,572 Depreciation expense for property and equipment was $285,000 $98,000 three March 31, 2020 2019, Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consist of the following: (In thousands) March 31, 2020 December 31, 2019 Accrued expenses and other current liabilities $ 337 $ 302 Other payables 676 1,018 Accrued compensation 1,762 1,554 Deferred revenue 282 324 Other 23 171 Total accrued expenses and other current liabilities $ 3,080 $ 3,369

Note 15 - Employee Benefit Plan

Note 15 - Employee Benefit Plan	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Defined Contribution Plan [Text Block]	1 5 . Employee Benefit Plan The Company sponsors a 401 may 100% $84,000 $50,000 three March 31, 2020 2019,

Note 16 - Subsequent Event

Note 16 - Subsequent Event	3 Months Ended
	Mar. 31, 2020
Notes to Financial Statements
Subsequent Events [Text Block]	1 6 . Subsequent Event Paycheck Protection Program We determined that we met the original eligibility requirements per the guidelines original established by the U.S. federal government as part of the CARES Act for the Pursuant to the Paycheck Protection Program (the “PPP”). As such, on April 20, 2020, $2,175,320 April 29, 2020. Casdin Financing On May 22, 2020, $20 $10.50. 1,904,762 Cashless warrant exercises On May 14, 2020, Taurus4757 2,747,970 3,871,405

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The condensed consolidated financial statements included herein have been prepared by BioLife Solutions, Inc. in accordance with generally accepted accounting principles in the United States (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for Quarterly Reports on Form 10 10 X not 10 December 31, 2019. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Astero Bio Corporation (“Astero,” and the Astero product line, “ThawStar” acquired on April 1, 2019), August 8, 2019), November 12, 2019). In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations, and cash flows. The results of operations for the interim periods presented are not Financial Statement Reclassification Certain classifications on the Condensed Consolidated Statements of Cash Flows related to Non cash lease expense and Accrued expenses and other current liabilities for the three March 31, 2019 no Significant Accounting P olicies There have been no three March 31, 2020, 10
Liquidity and Capital Resources [Policy Text Block]	Liquidity and Capital Resources On March 31, 2020 December 31, 2019, $6.4 April 1, 2019 $12.5 $8.5 not $484,000 2019 second 2020. August 8, 2019, 1,100,000 November 12, 2019, $11.0 $4.0 $15.0 not On May 22, 2020, $20 12 not 19 not may may 19 may not
Risk and Uncertainties, Policy [Policy Text Block]	Risks and Uncertainties On March 10, 2020, 19 one 19 six nine no We have already experienced certain disruptions to our business such as temporary closure of our offices and similar disruptions may may 19 19 may may 19 19 19 There are many uncertainties regarding the current pandemic of the novel coronavirus (“COVID- 19” 19 19 not first March 31, 2020, 19 may $1.5 $2.0 may 19
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of credit risk and business risk In the three March 31, 2020, 25% two three March 31, 2019, 34% two No 10% three March 31, 2020 2019. three March 31, 2020 2019, 66% 90%, 2019, December 31, 2020. March 31, 2020, two 33% December 31, 2019, two 25% The following table represents the Company’s total revenue by geographic area (based on the location of the customer): Three Months Ended March 31, Revenue by customers’ geographic locations 2020 2019 United States 74 % 60 % Canada 11 % 23 % Europe, Middle East, Africa (EMEA) 12 % 13 % Other 3 % 4 % Total revenue 100 % 100 %
New Accounting Pronouncements, Policy [Policy Text Block]	Recent accounting pronouncements In August 2018, 2018 13, 820 2018 13 8: December 31, 2020 January 1, 2020 no In December 2019, 2019 12, 740 2019 12 740, not 2019 12 December 31, 2021, 2020. no 2019 12 In June 2016, No. 2016 13, 326 2016 13 2016 13 December 15, 2022, In August 2018, No. 2018 15, 350 40 2018 15 December 15, 2019, January 1, 2020. January 1, 2020 no

Note 1 - Organization and Sig_2

Note 1 - Organization and Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Revenue from External Customers by Products and Services [Table Text Block]	Three Months Ended March 31, Revenue by customers’ geographic locations 2020 2019 United States 74 % 60 % Canada 11 % 23 % Europe, Middle East, Africa (EMEA) 12 % 13 % Other 3 % 4 % Total revenue 100 % 100 %

Note 2 - Fair Value Measureme_2

Note 2 - Fair Value Measurement (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	As of March 31, 20 20 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 6,400 $ — $ — $ 6,400 Convertible debt held at fair value — — 1,000 1,000 Total 6,400 — 1,000 7,400 Liabilities: Contingent consideration - business combinations — — 1,851 1,851 Warrant liability — — 17,667 17,667 Total $ — $ — $ 19,518 $ 19,518 As of December 31, 2019 Level 1 Level 2 Level 3 Total Assets: Money market accounts $ 6,448 $ — $ — $ 6,448 Convertible debt held at fair value — — 1,000 1,000 Total 6,448 — 1,000 7,448 Liabilities: Contingent consideration - business combinations — — 1,914 1,914 Warrant liability — — 39,602 39,602 Total $ — $ — $ 41,516 $ 41,516
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	March 31, December 31, (In thousands) 2020 2019 Beginning balance $ 1,000 $ 1,000 Purchases — — Change in fair value recognized in net income — — Total $ 1,000 $ 1,000
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	March 31, December 31, (In thousands) 2020 2019 Beginning balance $ 1,914 $ — Additions — 2,347 Change in fair value recognized in net income (63 ) 50 Payments earned, reclassified to accrued liabilities — (483 ) Total $ 1,851 $ 1,914
Warrant Liabilities [Member]
Notes Tables
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	March 31, December 31, (In thousands) 2020 2019 Beginning balance $ 39,602 $ 28,516 Exercised warrants (21 ) (1,749 ) Change in fair value recognized in net income (21,914 ) 12,835 Ending balance $ 17,667 $ 39,602

Note 3 - Acquisitions (Tables)

Note 3 - Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Business Acquisitions, by Acquisition [Table Text Block]	Cash consideration $ 12,521 Contingent consideration 1,491 Working capital adjustment (71 ) Total consideration transferred $ 13,941 Stock consideration for 55.6% equity interest purchased $ 19,932 Cash consideration $ 11,000 Stock consideration 4,000 Contingent consideration 856 Total consideration transferred $ 15,856
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	Cash and cash equivalents $ 11 Accounts receivable, net 154 Inventory 456 Customer relationships 160 Tradenames 470 Developed technology 2,840 In-process research and development 650 Goodwill 9,515 Other assets 99 Accounts payable (250 ) Other liabilities (164 ) Fair value of net assets acquired $ 13,941 Cash and cash equivalents $ 1,251 Accounts receivable, net 753 Prepaid expenses and other current assets 19 Property, plant and equipment, net 546 Operating right-of-use asset 233 Assets held for rent, net 2,441 Customer relationships 80 Tradenames 1,320 Developed technology 10,750 Goodwill 21,037 Accounts payable and accrued expenses (807 ) Deferred tax liabilities (1,541 ) Other liabilities (232 ) Fair value of net assets acquired $ 35,850 Accounts receivable, net $ 1,044 Inventory 3,232 Prepaid expenses and other current assets 29 Property, plant and equipment, net 3,615 Customer relationships 560 Tradenames 800 Developed technology 5,430 Goodwill 2,954 Accounts payable (1,197 ) Other liabilities (611 ) Fair value of net assets acquired $ 15,856
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 160 4 Tradenames 470 9 Developed technology 2,840 5 – 9 In-process research and development 650 9 Total identifiable intangible assets $ 4,120 Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 80 6 Tradenames 1,320 9 Developed technology 10,750 7 – 8 Total identifiable intangible assets $ 12,150 Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 560 6 Tradenames 800 6 Developed technology 5,430 9 Total identifiable intangible assets $ 6,790

Note 4 - Inventory (Tables)

Note 4 - Inventory (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Inventory, Current [Table Text Block]	(In thousands) March 31, 20 20 December 31, 201 9 Raw materials $ 3,282 $ 2,979 Work in progress 1,658 1,896 Finished goods 5,889 6,097 Total $ 10,829 $ 10,972

Note 5 - Assets Held for Rent (

Note 5 - Assets Held for Rent (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Scheduleof Assets Held for Rent [Table Text Block]	(In thousands) March 31, 2020 December 31, 2019 Shippers placed in service $ 3,748 $ 3,073 Accumulated deprecation (302 ) (174 ) Net 3,446 2,899 Shippers and related components in production 1,429 1,023 Total $ 4,875 $ 3,922

Note 6 - Goodwill and Intangi_2

Note 6 - Goodwill and Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Goodwill [Table Text Block]	(In thousands) Balance as of December 31, 2019 $ 33,637 Correction of an error related to CBS goodwill (131 ) Balance as of March 31, 2020 $ 33,506
Schedule of Finite-Lived Intangible Assets [Table Text Block]	(In thousands, except weighted average useful life) March 31, 2020 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (88 ) $ 712 5.0 Tradenames 2,590 (205 ) 2,385 7.4 Technology – acquired 19,020 (1,473 ) 17,547 7.8 In-process R&D (1) 650 — 650 9.0 Total intangible assets $ 23,060 $ (1,766 ) $ 21,294 7.7 (In thousands, except weighted average useful life) December 31, 2019 Finite-lived intangible assets: Gross Carrying Value Accumulated Amortization Net Carrying Value Weighted Average Useful Life (in years) Customer Relationships $ 800 $ (51 ) $ 749 5.6 Tradenames 2,590 (123 ) 2,467 8.1 Technology – acquired 19,020 (904 ) 18,116 8.4 In-process R&D (1) 650 — 650 9.0 Total intangible assets $ 23,060 $ (1,078 ) $ 21,982 8.3
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	(In thousands) For the Years Ended December 31, Estimated Amortization Expense 2020 (9 months remaining) $ 2,100 2021 2,825 2022 2,825 2023 2,795 2024 2,770 Thereafter 7,979 Total $ 21,294

Note 7 - Share-based Compensa_2

Note 7 - Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Three Month s Ended March 31, 20 20 Options Weighted Avg. Exercise Price Outstanding at beginning of period 1,570,455 $ 1.96 Granted — $ — Exercised (251,180 ) $ 1.84 Forfeited — $ — Expired — $ — Outstanding at March 31, 2020 1,319,275 $ 1.98 Service vesting-based stock options exercisable at March 31, 2020 1,263,377 $ 1.96 Three Month s Ended March 31, 2020 Options Wtd. Avg. Exercise Price Outstanding at beginning of period 737,497 $ 1.64 Granted — $ — Exercised (17,113 ) $ 1.64 Outstanding performance-based at March 31, 2020 720,384 $ 1.64 Performance-based stock options exercisable at March 31, 2020 720,384 $ 1.64
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Thr ee Months Ended March 31, 20 20 Number of Grant-Date Unvested outstanding at beginning of period 429,399 $ 13.25 Granted 175,971 $ 9.43 Vested (53 026 ) $ 12.90 Forfeited (7,000 ) $ 15.92 Unvested outstanding at March 31, 2020 545,344 $ 12.01
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended March 31, (In thousands) 20 20 201 9 Research and development costs $ 174 $ 67 Sales and marketing costs 229 154 General and administrative costs 577 278 Cost of product sales 133 32 Total $ 1,113 $ 531

Note 8 - Warrants (Tables)

Note 8 - Warrants (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Shares Wtd. Avg. Exercise Price Outstanding at December 31, 2019 3,959,005 $ 4.33 Exercised (2,000 ) 4.75 Outstanding at March 31, 2020 3,957,005 $ 4.33

Note 10 - Net Income (Loss) P_2

Note 10 - Net Income (Loss) Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Month s Ended March 31, (In thousands, except per share and share data) 2 020 201 9 Numerator: Net income (loss) attributable to common stockholders: Basic $ 18,364 $ (19,161 ) Diluted $ (174 ) $ (19,161 ) Denominator: Basic and diluted weighted average shares outstanding 21,010,817 18,648,397 Basic earnings per share $ 0.87 $ (1.03 ) Diluted earnings per share $ (0.01 ) $ (1.03 )

Note 12 - Revenue (Tables)

Note 12 - Revenue (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Revenues By Product Line [Table Text Block]	Three Months Ended March 31, (In thousands, except percentages) 2020 2019 Biopreservation media $ 8,672 $ 5,770 Automated thawing 394 –– evo shippers 438 –– Freezers and accessories 2,658 –– Total revenue $ 12,162 $ 5,770

Note 13 - Leases (Tables)

Note 13 - Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	(In thousands) Operating Leases Financing Leases 2020 $ 656 $ 11 2021 559 3 Total lease payments 1,215 14 Less: interest (57 ) (1 ) Total present value of lease liabilities $ 1,158 $ 13

Note 14 - Consolidated Balanc_2

Note 14 - Consolidated Balance Sheet Detail (Tables)	3 Months Ended
	Mar. 31, 2020
Notes Tables
Property, Plant and Equipment [Table Text Block]	(In thousands) March 31, 2020 December 31, 2019 Property and equipment Leasehold improvements $ 2,137 $ 2,112 Furniture and computer equipment 810 794 Manufacturing and other equipment 5,261 5,187 Subtotal 8,208 8,093 Less: Accumulated depreciation (2,801 ) (2,521 ) Net property and equipment $ 5,407 $ 5,572
Schedule of Accrued Liabilities [Table Text Block]	(In thousands) March 31, 2020 December 31, 2019 Accrued expenses and other current liabilities $ 337 $ 302 Other payables 676 1,018 Accrued compensation 1,762 1,554 Deferred revenue 282 324 Other 23 171 Total accrued expenses and other current liabilities $ 3,080 $ 3,369

Note 1 - Organization and Sig_3

Note 1 - Organization and Significant Accounting Policies (Details Textual)	Nov. 12, 2019USD ($)	Aug. 08, 2019USD ($)shares	Apr. 01, 2019USD ($)	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Jun. 30, 2020USD ($)	Dec. 31, 2019USD ($)	May 22, 2020USD ($)	May 14, 2020USD ($)	Dec. 31, 2018USD ($)
Cash and Cash Equivalents, at Carrying Value, Ending Balance				$ 6,400,000	$ 31,824,000		$ 6,448,000			$ 30,657,000
Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage				25.00%	34.00%
Number of Major Customers				2	2
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage				33.00%			25.00%
Number of Major Customers				2			2
CryoStor Products [Member] | Customer Concentration Risk [Member] | Revenue Benchmark [Member]
Concentration Risk, Percentage				66.00%	90.00%
Minimum [Member] | Biopreservation Media [Member]
Expected Incremental Revenue				$ 1,500,000
Maximum [Member] | Biopreservation Media [Member]
Expected Incremental Revenue				$ 2,000,000
Subsequent Event [Member] | Casdin Capital LLC [Member]
Share Repurchase Agreement, Amount of Shares to be Issued								$ 20,000,000	$ 20,000,000
Astero [Member]
Payments to Acquire Businesses, Gross			$ 12,521,000
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High			8,500,000
Payments to Acquire Businesses, Initial Cash Payment			8,000,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			$ 8,500,000
Astero [Member] | Forecast [Member]
Payment for Contingent Consideration Liability, Investing Activities						$ 484,000
SAVSU [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) | shares		1,100,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 19,932,000
CBS Acquisition [Member]
Payments to Acquire Businesses, Gross	$ 11,000,000
Payments to Acquire Businesses, Initial Cash Payment	11,000,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	4,000,000
CBS Acquisition [Member] | Earning Payments Payable in Each Calendar Year 2020, 2021, 2022, 2023, and 2024 [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 15,000,000

Note 1 - Organization and Sig_4

Note 1 - Organization and Significant Accounting Policies - Concentrations Risk by Geographic Locations (Details) - Revenue Benchmark [Member] - Geographic Concentration Risk [Member]	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue by customers’ geographic locations, percentage	100.00%	100.00%
UNITED STATES
Revenue by customers’ geographic locations, percentage	74.00%	60.00%
CANADA
Revenue by customers’ geographic locations, percentage	11.00%	23.00%
EMEA [Member]
Revenue by customers’ geographic locations, percentage	12.00%	13.00%
Geographic, Other [Member]
Revenue by customers’ geographic locations, percentage	3.00%	4.00%

Note 2 - Fair Value Measureme_3

Note 2 - Fair Value Measurement - Financial Assets and Liabilities on Recurring Basis (Details) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets	$ 7,400	$ 7,448
Liabilities	19,518	41,516
Contingent Consideration Liabilities [Member]
Liabilities	1,851
Warrant Liabilities [Member]
Liabilities	17,667	39,602
Money Market Funds [Member]
Assets	6,400	6,448
Convertible Debt Securities [Member]
Assets	1,000	1,000
Contingent Consideration Liabilities [Member]
Liabilities		1,914
Fair Value, Inputs, Level 1 [Member]
Assets	6,400	6,448
Liabilities
Fair Value, Inputs, Level 1 [Member] | Contingent Consideration Liabilities [Member]
Liabilities
Fair Value, Inputs, Level 1 [Member] | Warrant Liabilities [Member]
Liabilities
Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]
Assets	6,400	6,448
Fair Value, Inputs, Level 1 [Member] | Convertible Debt Securities [Member]
Assets
Fair Value, Inputs, Level 1 [Member] | Contingent Consideration Liabilities [Member]
Liabilities
Fair Value, Inputs, Level 2 [Member]
Assets
Liabilities
Fair Value, Inputs, Level 2 [Member] | Contingent Consideration Liabilities [Member]
Liabilities
Fair Value, Inputs, Level 2 [Member] | Warrant Liabilities [Member]
Liabilities
Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]
Assets
Fair Value, Inputs, Level 2 [Member] | Convertible Debt Securities [Member]
Assets
Fair Value, Inputs, Level 2 [Member] | Contingent Consideration Liabilities [Member]
Liabilities
Fair Value, Inputs, Level 3 [Member]
Assets	1,000	1,000
Liabilities	19,518	41,516
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Liabilities [Member]
Liabilities	1,851
Fair Value, Inputs, Level 3 [Member] | Warrant Liabilities [Member]
Liabilities	17,667	39,602
Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member]
Assets
Fair Value, Inputs, Level 3 [Member] | Convertible Debt Securities [Member]
Assets	$ 1,000	1,000
Fair Value, Inputs, Level 3 [Member] | Contingent Consideration Liabilities [Member]
Liabilities		$ 1,914

Note 2 - Fair Value Measureme_4

Note 2 - Fair Value Measurement - Fair Value of Assets Using Level 3 Input (Details) - Investments [Member] - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Beginning balance	$ 1	$ 1
Purchases
Change in fair value recognized in net income
Total	$ 1	$ 1

Note 2 - Fair Value Measureme_5

Note 2 - Fair Value Measurement - Fair Value of Liabilities Using Level 3 Input (Details) - Contingent Consideration Liabilities [Member] - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Beginning balance	$ 1,914
Additions		2,347
Change in fair value recognized in net income	(63)	50
Payments earned, reclassified to accrued liabilities		(483)
Total	$ 1,851	$ 1,914

Note 2 - Fair Value Measureme_6

Note 2 - Fair Value Measurement - Fair Value of Warrant Liabilities Using Level 3 Inputs (Details) - Warrant Liabilities [Member] - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Beginning balance	$ 39,602	$ 39,602	$ 28,516
Exercised warrants	(21)		(1,749)
Change in fair value recognized in net income	(21,914)		12,835
Total	$ 17,667	$ 39,602	$ 39,602

Note 3 - Acquisitions (Details

Note 3 - Acquisitions (Details Textual) - USD ($)	Nov. 12, 2019	Aug. 08, 2019	Apr. 01, 2019	Mar. 31, 2020	Dec. 31, 2019	Nov. 11, 2019	Aug. 07, 2019	Mar. 31, 2019
Goodwill, Ending Balance				$ 33,506,000	$ 33,637,000
Equity Method Investments				$ 27,000
SAVSU [Member]
Equity Method Investments		$ 5,800,000
Astero [Member]
Payments to Acquire Businesses, Gross			$ 12,521,000
Payments to Acquire Businesses, Initial Cash Payment			8,000,000
Payments to Acquire Businesses, Deferred Cash Payment			4,500,000
Business Combination, Consideration Transferred, Liabilities Incurred			1,491,000
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High			8,500,000
Business Combination, Contingent Consideration, Liability, Total			1,500,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Tangible Assets			324,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets			4,100,000
Goodwill, Ending Balance			9,515,000					$ 9,500,000
Business Acquisition, Goodwill, Expected Tax Deductible Amount			1,100,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total			13,941,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles			12,150,000					$ 4,120,000
Business Combination, Consideration Transferred, Total			13,941,000
Astero [Member] | Earnout Payments Payable in Each Calendar Years of 2019, 2020 and 2021 [Member]
Business Combination, Consideration Transferred, Liabilities Incurred			3,500,000
Astero [Member] | Earnout Payment for Calendar Year 2021 [Member]
Business Combination, Consideration Transferred, Liabilities Incurred			$ 5,000,000
SAVSU [Member]
Goodwill, Ending Balance		$ 19,500,000					$ 21,037,000
Business Combinations, Number of Shares Acquired (in shares)		8,616
Business Acquisition, Percentage of Voting Interests Acquired		55.60%
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares)		1,100,000
Share Price (in dollars per share)		$ 18.12
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable		$ 19,932,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total		35,800,000					$ 35,850,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value		$ 15,900,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage		44.00%
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain (Loss), Net, Total		$ 10,100,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets, Net		4,200,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		12,200,000
Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination, Total		$ 35,800,000
CBS Acquisition [Member]
Payments to Acquire Businesses, Gross	$ 11,000,000
Payments to Acquire Businesses, Initial Cash Payment	11,000,000
Business Combination, Consideration Transferred, Liabilities Incurred	856,000
Goodwill, Ending Balance	3,100,000					$ 2,954,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable	4,000,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net, Total						15,856,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Tangible Assets, Net	6,000,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles	6,800,000					$ 6,790,000
Business Combination, Consideration Transferred, Total	15,856,000
Business Combination, Cash Holdback Escrow to Satisfy Indemnification Claims	550,000
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable, Escrow Holdback	3,000,000
CBS Acquisition [Member] | Earning Payments Payable in Each Calendar Year 2020, 2021, 2022, 2023, and 2024 [Member]
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High	$ 15,000,000

Note 3 - Acquisitions - Conside

Note 3 - Acquisitions - Consideration (Details) - USD ($)	Nov. 12, 2019	Aug. 08, 2019	Apr. 01, 2019
Astero [Member]
Cash consideration			$ 12,521,000
Contingent consideration			1,491,000
Working capital adjustment			(71,000)
Total consideration transferred			$ 13,941,000
SAVSU [Member]
Stock consideration		$ 19,932,000
CBS Acquisition [Member]
Cash consideration	$ 11,000,000
Contingent consideration	856,000
Total consideration transferred	15,856,000
Stock consideration	$ 4,000,000

Note 3 - Acquisitions - Consi_2

Note 3 - Acquisitions - Consideration (Details) (Parentheticals)	Aug. 08, 2019
SAVSU [Member]
Percentage equity interest purchased	55.60%

Note 3 - Acquisitions - Fair Va

Note 3 - Acquisitions - Fair Value of Net Assets Acquired (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Nov. 12, 2019	Nov. 11, 2019	Aug. 08, 2019	Aug. 07, 2019	Apr. 01, 2019	Mar. 31, 2019
Goodwill	$ 33,506,000	$ 33,637,000
Astero [Member]
Cash and cash equivalents							$ 11,000
Accounts receivable, net							154,000
Inventory							456,000
Intangible assets							12,150,000	$ 4,120,000
Goodwill							9,515,000	9,500,000
Other assets							99,000
Accounts payable							(250,000)
Other liabilities							164,000
Fair value of net assets acquired							13,941,000
Other liabilities							(164,000)
Fair value of net assets acquired							13,941,000
Inventory							456,000
Astero [Member] | Customer Relationships [Member]
Intangible assets							160,000	160,000
Astero [Member] | Trade Names [Member]
Intangible assets							470,000	470,000
Astero [Member] | Developed Technology Rights [Member]
Intangible assets							2,840,000	2,840,000
Astero [Member] | In Process Research and Development [Member]
Intangible assets							$ 650,000	$ 650,000
SAVSU [Member]
Cash and cash equivalents						$ 1,251,000
Accounts receivable, net						753,000
Intangible assets					$ 12,200,000
Goodwill					19,500,000	21,037,000
Accounts payable						(807,000)
Other liabilities						232,000
Fair value of net assets acquired					35,800,000	35,850,000
Prepaid expenses and other current assets						19,000
Property, plant and equipment, net						546,000
Operating right-of-use asset					233,000	233,000
Assets held for rent, net						2,441,000
Deferred tax liabilities						(1,541,000)
Other liabilities						(232,000)
Fair value of net assets acquired					$ 35,800,000	35,850,000
SAVSU [Member] | Customer Relationships [Member]
Intangible assets						80,000
SAVSU [Member] | Trade Names [Member]
Intangible assets						1,320,000
SAVSU [Member] | Developed Technology Rights [Member]
Intangible assets						$ 10,750,000
CBS Acquisition [Member]
Accounts receivable, net				$ 1,044,000
Inventory				3,232,000
Intangible assets			$ 6,800,000	6,790,000
Goodwill			$ 3,100,000	2,954,000
Accounts payable				(1,197,000)
Other liabilities				611,000
Fair value of net assets acquired				15,856,000
Prepaid expenses and other current assets				29,000
Property, plant and equipment, net				3,615,000
Other liabilities				(611,000)
Fair value of net assets acquired				15,856,000
Inventory				3,232,000
CBS Acquisition [Member] | Customer Relationships [Member]
Intangible assets				560,000
CBS Acquisition [Member] | Trade Names [Member]
Intangible assets				800,000
CBS Acquisition [Member] | Developed Technology Rights [Member]
Intangible assets				$ 5,430,000

Note 3 - Acquisitions - Acquire

Note 3 - Acquisitions - Acquired Intangible Assets (Details) - USD ($)	Nov. 11, 2019	Apr. 01, 2019	Mar. 31, 2019	Nov. 12, 2019
Astero [Member]
Intangible assets		$ 12,150,000	$ 4,120,000
Astero [Member] | Customer Relationships [Member]
Intangible assets		$ 160,000	$ 160,000
Intangible assets, estimated useful life (Year)		6 years	4 years
Astero [Member] | Trade Names [Member]
Intangible assets		$ 470,000	$ 470,000
Intangible assets, estimated useful life (Year)		9 years	9 years
Astero [Member] | Developed Technology Rights [Member]
Intangible assets		$ 2,840,000	$ 2,840,000
Astero [Member] | Developed Technology Rights [Member] | Minimum [Member]
Intangible assets, estimated useful life (Year)			5 years
Astero [Member] | Developed Technology Rights [Member] | Maximum [Member]
Intangible assets, estimated useful life (Year)			9 years
Astero [Member] | Technology-Based Intangible Assets [Member]
Intangible assets		$ 10,750,000
Astero [Member] | Technology-Based Intangible Assets [Member] | Minimum [Member]
Intangible assets, estimated useful life (Year)		7 years
Astero [Member] | Technology-Based Intangible Assets [Member] | Maximum [Member]
Intangible assets, estimated useful life (Year)		8 years
Astero [Member] | In Process Research and Development [Member]
Intangible assets		$ 650,000	$ 650,000
Intangible assets, estimated useful life (Year)			9 years
CBS Acquisition [Member]
Intangible assets	$ 6,790,000			$ 6,800,000
CBS Acquisition [Member] | Customer Relationships [Member]
Intangible assets	$ 560,000
Intangible assets, estimated useful life (Year)	6 years
CBS Acquisition [Member] | Trade Names [Member]
Intangible assets	$ 800,000
Intangible assets, estimated useful life (Year)	6 years
CBS Acquisition [Member] | Developed Technology Rights [Member]
Intangible assets	$ 5,430,000
Intangible assets, estimated useful life (Year)	9 years

Note 4 - Inventory - Summary of

Note 4 - Inventory - Summary of Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Raw materials	$ 3,282	$ 2,979
Work in progress	1,658	1,896
Finished goods	5,889	6,097
Total	$ 10,829	$ 10,972

Note 5 - Assets Held for Rent_2

Note 5 - Assets Held for Rent (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Assets Held for Rent, Depreciation	$ 128,000	$ 0

Note 5 - Assets Held for Rent -

Note 5 - Assets Held for Rent - Assets Held for Rent (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Shippers placed in service	$ 3,748	$ 3,073
Accumulated deprecation	(302)	(174)
Net	3,446	2,899
Shippers and related components in production	1,429	1,023
Total	$ 4,875	$ 3,922

Note 6 - Goodwill and Intangi_3

Note 6 - Goodwill and Intangible Assets (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Goodwill, Purchase Accounting Adjustments	$ (131,000)
Increase (Decrease) in Accounts Payable, Total	561,000
Amortization of Intangible Assets, Total	688,000	$ 0
CBS Acquisition [Member] | Immaterial Error [Member]
Goodwill, Purchase Accounting Adjustments	(131,000)
Increase (Decrease) in Accounts Payable, Total	$ (131,000)

Note 6 - Goodwill and Intangi_4

Note 6 - Goodwill and Intangible Assets - Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Balance	$ 33,637
Correction of an error related to CBS goodwill	(131)
Balance	$ 33,506

Note 6 - Goodwill and Intangi_5

Note 6 - Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($)		3 Months Ended	12 Months Ended
		Mar. 31, 2020	Dec. 31, 2019
Gross Carrying Value		$ 23,060,000	$ 23,060,000
Accumulated Amortization		(1,766,000)	(1,078,000)
Net Carrying Value		$ 21,294,000	$ 21,982,000
Weighted Average [Member]
Weighted Average Useful Life (Year)		7 years 255 days	8 years 109 days
Customer Relationships [Member]
Gross Carrying Value		$ 800,000	$ 800,000
Accumulated Amortization		(88,000)	(51,000)
Net Carrying Value		$ 712,000	$ 749,000
Customer Relationships [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)		5 years	5 years 219 days
Trade Names [Member]
Gross Carrying Value		$ 2,590,000	$ 2,590,000
Accumulated Amortization		(205,000)	(123,000)
Net Carrying Value		$ 2,385,000	$ 2,467,000
Trade Names [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)		7 years 146 days	8 years 36 days
Technology-Based Intangible Assets [Member]
Gross Carrying Value		$ 19,020,000	$ 19,020,000
Accumulated Amortization		(1,473,000)	(904,000)
Net Carrying Value		$ 17,547,000	$ 18,116,000
Technology-Based Intangible Assets [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)		7 years 292 days	8 years 146 days
In Process Research and Development [Member]
Gross Carrying Value	[1]	$ 650,000	$ 650,000
Accumulated Amortization
Net Carrying Value	[1]	$ 650,000	$ 650,000
In Process Research and Development [Member] | Weighted Average [Member]
Weighted Average Useful Life (Year)	[1]	9 years	9 years
[1]	In-process R&D represents the fair value of incomplete research and development that has not yet reached technological feasibility. We will amortize the asset upon technological feasibility, which has reach technological feasibility and been placed in service in the second quarter of 2020.

Note 6 - Goodwill and Intangi_6

Note 6 - Goodwill and Intangible Assets - Future Amortization Expense (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
2020 (9 months remaining)	$ 2,100
2021	2,825,000
2022	2,825,000
2023	2,795,000
2024	2,770,000
Thereafter	7,979,000
Total	$ 21,294,000	$ 21,982,000

Note 7 - Share-based Compensa_3

Note 7 - Share-based Compensation (Details Textual) - USD ($)	Mar. 25, 2020	Apr. 01, 2019	Feb. 25, 2019	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Share-based Payment Arrangement, Expense				$ 1,113,000	$ 531,000
Share-based Payment Arrangement, Option [Member]
Share-based Payment Arrangement, Expense				61,000	144,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value				9,900,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value				9,500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value				3,000,000	1,400,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				$ 86,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)				1 year 73 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)				0		0
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares)
Performance Shares [Member] | Management Performance Bonus Plan 2017 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value				$ 5,700,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term (Year)				1 year 255 days
Restricted Stock [Member]
Share-based Payment Arrangement, Expense				$ 394,000	255,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				$ 5,700,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)				3 years 109 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value				$ 1,700,000	2,600,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value				$ 813,000	853,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)				175,971
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)				$ 9.43
Performance-based Restricted Stock [Member]
Share-based Payment Arrangement, Expense				$ 189,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				$ 571,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)				292 days
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)	82,805
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 9.18
Performance-based Restricted Stock [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	0.00%
Performance-based Restricted Stock [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	125.00%
Performance-based Restricted Stock in Lieu of Cash [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)	34,154
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share)	$ 9.18
Market-based Restricted Stock [Member]
Share-based Payment Arrangement, Expense				$ 469,000	$ 132,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				$ 2,600,000
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)				1 year 73 days
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period (in shares)	109,140	29,604	94,247
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number, Ending Balance	78.00%			69.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0.00%			0.00%
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	0.30%			2.50%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)	2 years			2 years
Market-based Restricted Stock [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	0.00%			0.00%
Market-based Restricted Stock [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Awards	200.00%			200.00%

Note 7 - Share-based Compensa_4

Note 7 - Share-based Compensation - Stock Option Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Option [Member]
Outstanding at beginning of period (in shares)	1,570,455
Outstanding at beginning of period (in dollars per share)	$ 1.96
Granted (in shares)	0	0
Granted, weighted average exercise price (in dollars per share)
Exercised (in shares)	(251,180)
Exercised, weighted average exercise price (in dollars per share)	$ 1.84
Forfeited (in shares)
Forfeited, weighted average exercise price (in dollars per share)
Expired (in shares)
Expired, weighted average exercise price (in dollars per share)
Outstanding (in shares)	1,319,275	1,570,455
Outstanding at beginning of year, weighted average exercise price (in dollars per share)	$ 1.98	$ 1.96
Service vesting-based stock options exercisable at March 31, 2020 (in shares)	1,263,377
Service vesting-based stock options exercisable at March 31, 2020 (in dollars per share)	$ 1.96
Performance Shares [Member]
Outstanding at beginning of period (in shares)	737,497
Outstanding at beginning of period (in dollars per share)	$ 1.64
Granted (in shares)
Granted, weighted average exercise price (in dollars per share)
Exercised (in shares)	(17,113)
Exercised, weighted average exercise price (in dollars per share)	$ 1.64
Outstanding (in shares)	720,384	737,497
Outstanding at beginning of year, weighted average exercise price (in dollars per share)	$ 1.64	$ 1.64
Service vesting-based stock options exercisable at March 31, 2020 (in shares)	720,384
Service vesting-based stock options exercisable at March 31, 2020 (in dollars per share)	$ 1.64

Note 7 - Share-based Compensa_5

Note 7 - Share-based Compensation - Restricted Stock Activity (Details) - Restricted Stock [Member]	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Unvested outstanding at beginning of period (in shares) | shares	429,399
Unvested outstanding at beginning of period (in dollars per share) | $ / shares	$ 13.25
Unvested granted (in shares) | shares	175,971
Granted, grant date fair value (in dollars per share) | $ / shares	$ 9.43
Vested (in shares) | shares	(53,026)
Vested, grant date fair value (in dollars per share) | $ / shares	$ 12.90
Forfeited (in shares) | shares	(7,000)
Forfeited, grant date fair value (in dollars per share) | $ / shares	$ 15.92
Unvested outstanding (in shares) | shares	545,344
Unvested outstanding, grant date fair value (in dollars per share) | $ / shares	$ 12.01

Note 7 - Share-based Compensa_6

Note 7 - Share-based Compensation - Stock Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Stock compensation expense	$ 1,113	$ 531
Research and Development Expense [Member]
Stock compensation expense	174	67
Selling and Marketing Expense [Member]
Stock compensation expense	229	154
General and Administrative Expense [Member]
Stock compensation expense	577	278
Cost of Sales [Member]
Stock compensation expense	$ 133	$ 32

Note 8 - Warrants (Details Text

Note 8 - Warrants (Details Textual) - $ / shares	May 14, 2020	Mar. 31, 2020	Dec. 31, 2019	May 31, 2016	Mar. 31, 2014
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 4.33	$ 4.33
Class of Warrant or Right, Exercised During Period (in shares)		2,000
Class of Warrant or Right, Outstanding (in shares)		3,957,005	3,959,005
Warrants to Purchase Common Stock [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)					6,910,283
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)					$ 4.75
Warrants in Connection with WAVI Credit Facility [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)				550,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)				$ 1.75
WAVI Holding AG and Taurus4757 GmbH Warrants [Member] | Subsequent Event [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)	$ 4.75
Stock Issued During Period, Shares, Warrant Exercises (in shares)	2,747,970
Class of Warrant or Right, Exercised During Period (in shares)	3,871,405
Class of Warrant or Right, Outstanding (in shares)	85,600

Note 8 - Warrants - Summary of

Note 8 - Warrants - Summary of Warrant Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Outstanding, number of shares (in shares) | shares	3,959,005
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 4.33
Exercised, number of shares (in shares) | shares	(2,000)
Exercised, weighted average exercise price (in dollars per share) | $ / shares	$ 4.75
Outstanding, number of shares (in shares) | shares	3,957,005
Outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 4.33

Note 10 - Net Income (Loss) P_3

Note 10 - Net Income (Loss) Per Common Share (Details Textual) - shares shares in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Share-based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	1.9	2.7
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)	2.7	3

Note 10 - Net Income (Loss) P_4

Note 10 - Net Income (Loss) Per Common Share - Calculation of Diluted Shares (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Basic	$ 18,364	$ (19,161)
Diluted	$ (174)	$ (19,161)
Basic and diluted weighted average shares outstanding (in shares)	21,010,817	18,648,397
Basic earnings per share (in dollars per share)	$ 0.87	$ (1.03)
Diluted earnings per share (in dollars per share)	$ (0.01)	$ (1.03)

Note 12 - Revenue (Details Text

Note 12 - Revenue (Details Textual)	3 Months Ended
	Mar. 31, 2020
Number of Operating Segments	1

Note 12 - Revenue - Revenues by

Note 12 - Revenue - Revenues by Product Line (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Total revenue	$ 12,162	$ 5,770
Biopreservation Media [Member]
Total revenue	8,672	5,770
Automated Thawing Products [Member]
Total revenue	394
Evo Shippers [Member]
Total revenue	438
Freezers and Accessories [Member]
Total revenue	$ 2,658

Note 13 - Leases (Details Textu

Note 13 - Leases (Details Textual)	3 Months Ended
	Mar. 31, 2020USD ($)ft²	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)	Aug. 08, 2019USD ($)	Aug. 07, 2019USD ($)	Jan. 01, 2019USD ($)
Operating Lease, Weighted Average Discount Rate, Percent	6.50%
Finance Lease, Weighted Average Discount Rate, Percent	8.10%
Operating Lease, Weighted Average Remaining Lease Term (Year)	1 year 182 days
Finance Lease, Weighted Average Remaining Lease Term (Year)	328 days
Operating Lease, Right-of-Use Asset	$ 892,000		$ 1,040,000			$ 1,300,000
Operating Lease, Liability, Total	1,158,000					$ 1,800,000
Lease Cost, Operating Leases	229,000
Operating Lease, Cost	170,000
Short-term Lease, Cost	59,000
Variable Lease, Cost	0
Operating Lease, Payments	$ 217,000
Operating Leases, Rent Expense, Net, Total		$ 142,000
SAVSU [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-of-use Asset				$ 233,000	$ 233,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liability				$ 232,000
Bothell, Washington Headquarters [Member]
Area of Real Estate Property (Square Foot) | ft²	32,106
Lessee, Operating Lease, Renewal Term (Year)	5 years
Monthly Base Rent Expense	$ 63,000
Menlo Park, California Location [Member]
Area of Real Estate Property (Square Foot) | ft²	1,250
Monthly Base Rent Expense	$ 5,000
Albuquerque, New Mexico Location [Member]
Area of Real Estate Property (Square Foot) | ft²	9,932
Monthly Base Rent Expense	$ 9,000
Detroit, Michigan Location [Member]
Area of Real Estate Property (Square Foot) | ft²	106,998
Lessee, Operating Lease, Renewal Term (Year)	5 years
Monthly Base Rent Expense	$ 15,000

Note 13 - Leases - Maturities o

Note 13 - Leases - Maturities of Lease Liabilities (Details) - USD ($)	Mar. 31, 2020	Jan. 01, 2019
2020, operating leases	$ 656,000
2020, financing leases	11,000
2021, operating leases	559,000
2021, financing leases	3,000
Total operating lease payments	1,215,000
Total financing lease payments	14,000
Less: operating lease interest	(57,000)
Less: financing lease interest	(1,000)
Total present value of operating lease liabilities	1,158,000	$ 1,800,000
Total present value of financing lease liabilities	$ 13,000

Note 14 - Consolidated Balanc_3

Note 14 - Consolidated Balance Sheet Detail (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Depreciation, Total	$ 285,000	$ 98,000

Note 14 - Consolidated Balanc_4

Note 14 - Consolidated Balance Sheet Detail - Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Property and equipment	$ 8,208	$ 8,093
Less: Accumulated depreciation	(2,801)	(2,521)
Net property and equipment	5,407	5,572
Leasehold Improvements [Member]
Property and equipment	2,137	2,112
Furniture and Computer Equipment [Member]
Property and equipment	810	794
Manufacturing Facility [Member]
Property and equipment	$ 5,261	$ 5,187

Note 14 - Consolidated Balanc_5

Note 14 - Consolidated Balance Sheet Detail - Accrued Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Accrued expenses and other current liabilities	$ 337	$ 302
Other payables	676	1,018
Accrued compensation	1,762	1,554
Deferred revenue	282	324
Other	23	171
Total accrued expenses and other current liabilities	$ 3,080	$ 3,369

Note 15 - Employee Benefit Pl_2

Note 15 - Employee Benefit Plan (Details Textual) - Defined Contribution Plan, 401 K [Member] - Pension Plan [Member] - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay	100.00%
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 84,000	$ 50,000

Note 16 - Subsequent Event (Det

Note 16 - Subsequent Event (Details Textual) - USD ($)	May 14, 2020	Apr. 29, 2020	Apr. 20, 2020	Mar. 31, 2020	May 22, 2020
Class of Warrant or Right, Exercised During Period (in shares)				2,000
Subsequent Event [Member]
Proceeds from Paycheck Protection Program Under CARES Act			$ 2,175,320
Repayments of Loan From Paycheck Protection Program Under CARES Act		$ 2,175,320
Subsequent Event [Member] | WAVI Holding AG and Taurus4757 GmbH Warrants [Member]
Stock Issued During Period, Shares, Warrant Exercises (in shares)	2,747,970
Class of Warrant or Right, Exercised During Period (in shares)	3,871,405
Subsequent Event [Member] | Casdin Capital LLC [Member]
Share Repurchase Agreement, Amount of Shares to be Issued	$ 20,000,000				$ 20,000,000
Share Repurchase Agreement, Shares Issued, Price Per Share (in dollars per share)	$ 10.50
Share Repurchase Agreement, Shares to be Issued (in shares)	1,904,762